myTomorrows logo

How to Pass the myTomorrows Sales Interview in 2026

Growth · Sales Interview Guide

Sign up to see ATSHeadquartered in Netherlands

Interview language: English

The myTomorrows DNA (TL;DR)

Connecting physicians with pre-approval medicine via Expanded Access Programs requires candidates to balance regulatory compliance with patient urgency. Evaluation centers on how effectively you navigate clinical trial data and articulate risk-benefit trade-offs to pharma partners.

The myTomorrows Interview Loop

Your onsite loop will typically consist of 5 rounds.

  1. 1

    Round 1

    Recruiter Screen
    Motivation, territory fit, logistics.
  2. 2

    Round 2

    Sales Pitch / Demo
    Pitching the company's product to a mock prospect.
  3. 3

    Round 3

    Deal Strategy
    Pipeline management, multi-stakeholder navigation, MEDDIC qualification.
  4. 4

    Round 4

    Customer Discovery
    Asking diagnostic questions, surfacing pain, qualifying.
  5. 5

    Round 5

    Behavioral / Leadership
    Past evidence of ownership, influence, resolving conflict.

The Danger Zone: Top Reasons Candidates Fail

Based on our database of myTomorrows interview outcomes, avoid these common traps:

  • Assuming regulatory requirements are uniform across geographies
  • Misidentifying a local MSL or clinical study manager as the Economic Buyer with budget authority
  • Focusing purely on transactional software sales tactics without acknowledging regulatory lead times
  • Failing to break down the workflow into discrete time-consuming operational steps

Test Yourself: Real myTomorrows Questions

Three real prompts pulled from our database.

Type · objection-handling

Pitch our expanded access platform to a mid-sized biotech VP of Clinical Operations who is reluctant to launch a pre-approval access program because they fear it will cannibalize enrollment in their ongoing Phase III trial.

Type · competitive-pitch

You are pitching to a Head of Medical Affairs who agrees that expanded access is valuable but claims their regional medical liaisons (MSLs) can handle country-by-country physician inquiries using spreadsheets and manual workflows. Pitch the value of dedicated technology-enabled workflows.

Type · qualification-framework

Using the MEDDIC framework, how would you identify and secure the Economic Buyer for a multi-country expanded access program deal in an enterprise pharma company where decisions involve Clinical Operations, Medical Affairs, Regulatory, and Market Access?

+ many more questions, signals, and worked examples

Sign up to unlock the full myTomorrows grading rubric

Unlock the myTomorrows rubric, free

myTomorrows Interview Question Bank

A sample from our database, grouped by round. Sign up to see the full set.

8 of 15 questions shown

1

Recruiter Screen

1
  1. 1

    Type · motivation-fit

    What draws you to enterprise sales in the expanded access and compassionate use space, and how do you handle selling complex services to bio-pharma clients where sales cycles depend heavily on regulatory timelines rather than standard fiscal budgets?
2

Sales Pitch / Demo

4
  1. 2

    Type · objection-handling

    Pitch our expanded access platform to a mid-sized biotech VP of Clinical Operations who is reluctant to launch a pre-approval access program because they fear it will cannibalize enrollment in their ongoing Phase III trial.
  2. 3

    Type · executive-pitch

    Deliver a 3-minute executive pitch to a Chief Medical Officer at a rare disease drug manufacturer explaining why outsourcing expanded access management to a dedicated platform is safer and more cost-effective than managing ad-hoc compassionate use requests in-house.
  3. + 2 more questions in this round (sign up to unlock)
3

Deal Strategy

4
  1. 4

    Type · qualification-framework

    Using the MEDDIC framework, how would you identify and secure the Economic Buyer for a multi-country expanded access program deal in an enterprise pharma company where decisions involve Clinical Operations, Medical Affairs, Regulatory, and Market Access?
  2. 5

    Type · pipeline-milestones

    A biotech client is eager to sign an expanded access contract for their lead oncology compound, but their lead drug candidate is still 6 months away from completing Phase II data readouts. How do you structure the deal stages and pilot terms to secure commitment now without stalling the pipeline?
  3. + 2 more questions in this round (sign up to unlock)
4

Customer Discovery

5
  1. 6

    Type · diagnostic-discovery

    What diagnostic questions would you ask a Head of Rare Diseases to uncover whether their current process for handling unsolicited expanded access requests from physicians is creating compliance exposure or operational bottleneck?
  2. 7

    Type · regulatory-discovery

    When speaking with a VP of Regulatory Affairs at a global pharma firm, how do you uncover their pain points regarding local-country regulations for pre-approval drug distribution across Europe and Latin America?
  3. + 3 more questions in this round (sign up to unlock)
5

Behavioral / Leadership

1
  1. 8

    Type · deal-salvage

    Walk me through a complex enterprise deal in the healthcare or life sciences sector where a mid-funnel regulatory or legal issue threatened to stall contract execution, and explain how you aligned cross-functional stakeholders to salvage the deal.

Unlock all 15 myTomorrows questions, free

No credit card. Every question with its framework, the grading signals interviewers score against, and a worked answer for each.

Unlock all 15 myTomorrows questions

Interview tracks at myTomorrows

How myTomorrows's DNA translates across functions. Pick your role.

Compare myTomorrows with similar employers

Same DNA, different bar. Browse the closest companies in our database and see how their loops differ.

Practice myTomorrows interviews end-to-end

Sample answers

What a strong answer to these myTomorrows interview questions shows.

Pitch our expanded access platform to a mid-sized biotech VP of Clinical Operations who is reluctant to launch a pre-approval access program because they fear it will cannibalize enrollment in their ongoing Phase III trial.

A strong answer shows: Ability to handle complex clinical/regulatory objections; Skill in positioning pre-approval access as complementary to ongoing clinical trials.

You are pitching to a Head of Medical Affairs who agrees that expanded access is valuable but claims their regional medical liaisons (MSLs) can handle country-by-country physician inquiries using spreadsheets and manual workflows. Pitch the value of dedicated technology-enabled workflows.

A strong answer shows: Navigating internal operational inertia; Articulating the risk of non-automated compliance tracking in global medical access.

Frequently asked questions

How long does the myTomorrows interview process take?

Most candidates spend between 4 and 8 weeks from recruiter screen to offer. The onsite loop itself runs in a single day or is split across two half-days, with debrief and offer typically within 5 business days after.

How should I prepare specifically for myTomorrows?

Focus on three things: (1) the company DNA shown above - what they actually grade for, (2) the rounds in your loop, especially the round most candidates underestimate, and (3) drilling on the question types in this guide using a structured framework like CIRCLES or STAR.

Does this apply to engineering or design roles at myTomorrows?

The DNA stays the same - what changes is the round mix. SWE candidates face coding screens instead of Product Sense; designers face portfolio reviews and design exercises. The "what they value" and behavioral signals carry across all functions.

WorkfiveExplore careers on Workfive

Unlock the free myTomorrows interview guide

Sign up